Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Desmond A O'Farrell, M.Sc.

Concepts (135)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Brachytherapy26202312241.630 Why?
Radiotherapy Planning, Computer-Assisted13202316590.590 Why?
Radiotherapy Dosage22202328950.430 Why?
Uterine Cervical Neoplasms5202120080.290 Why?
Genital Neoplasms, Female220235320.220 Why?
Carcinoma, Merkel Cell320133210.220 Why?
Rectum520178910.200 Why?
Penile Neoplasms120201610.160 Why?
Radiation Injuries3201311840.150 Why?
Carcinoma, Adenosquamous12016660.130 Why?
Iodine Radioisotopes3200910320.130 Why?
Colon, Sigmoid320171240.130 Why?
Organs at Risk220173580.130 Why?
Neoplasm Recurrence, Local8201692450.120 Why?
Software Validation12014590.120 Why?
Catheters320234200.120 Why?
Radiotherapy, Computer-Assisted22010900.110 Why?
Cystadenocarcinoma, Papillary12012560.110 Why?
Radiometry420148130.100 Why?
Catheters, Indwelling120144280.100 Why?
Adenocarcinoma, Clear Cell120122170.090 Why?
Chordoma319993460.090 Why?
Skin Diseases1202010880.090 Why?
Prostatic Neoplasms42014110750.090 Why?
Skull Base Neoplasms319992690.090 Why?
Endometrial Neoplasms2201213560.090 Why?
Urinary Bladder3201711510.080 Why?
Carcinoid Tumor220092240.080 Why?
Radiation Protection120124240.080 Why?
Skin Neoplasms3201357990.070 Why?
Imaging, Three-Dimensional2201340470.070 Why?
Salvage Therapy1201412640.070 Why?
Thoracic Neoplasms120092650.070 Why?
Polyethylene Glycols1201211880.070 Why?
Stereotaxic Techniques120085490.060 Why?
Vaginal Neoplasms120061040.060 Why?
Radiotherapy2200814980.060 Why?
Neoplasm Metastasis2201348880.060 Why?
Sarcoma2201317840.060 Why?
Uterine Neoplasms1201214130.060 Why?
Mediastinal Neoplasms120064020.060 Why?
Consensus1201330980.050 Why?
Magnetic Resonance Imaging52023362710.050 Why?
Treatment Outcome122020642420.050 Why?
Dose-Response Relationship, Radiation320138820.050 Why?
Ultrasonography1201459510.050 Why?
Carcinoma, Squamous Cell1201640210.050 Why?
Aged, 80 and over112020585590.050 Why?
Societies, Medical1201338870.050 Why?
Radiotherapy, Adjuvant3201317880.040 Why?
Aged1720201678890.040 Why?
Adenocarcinoma1201663250.040 Why?
Cicatrix120057800.040 Why?
Breast Neoplasms32013209990.040 Why?
Photons219995810.040 Why?
Humans3120237576500.040 Why?
Automation120205810.040 Why?
Radiation Dosage2201719570.030 Why?
Tomography, X-Ray Computed62020204990.030 Why?
Middle Aged1520202192190.030 Why?
Practice Guidelines as Topic1201373660.030 Why?
Chondrosarcoma119982960.030 Why?
Vagina220128280.030 Why?
SEER Program1202014540.030 Why?
Female1820233899850.030 Why?
Mammaplasty1200512390.030 Why?
Mammography1200524240.030 Why?
Protons1199811120.030 Why?
Liver Neoplasms1200843130.030 Why?
Brain Stem119978570.030 Why?
Retrospective Studies72017799820.030 Why?
Follow-Up Studies42014390180.020 Why?
Tumor Burden1201618870.020 Why?
Temporal Lobe1199816880.020 Why?
Watchful Waiting120144930.020 Why?
Feasibility Studies2201451950.020 Why?
Adult1120172197470.020 Why?
Disease-Free Survival2201668080.020 Why?
Male1320203582270.020 Why?
Analysis of Variance2201362310.020 Why?
Survival Rate22013126850.020 Why?
Mastectomy2200818320.020 Why?
Neoplasm Staging22013110830.020 Why?
Mediastinum120092670.020 Why?
Mastectomy, Segmental120139720.020 Why?
Time Factors32016398150.020 Why?
Particle Accelerators120081740.020 Why?
Technology, Radiologic120071600.020 Why?
Hydrogels120127230.020 Why?
Prostate1201417610.020 Why?
Prospective Studies52013541080.020 Why?
Urethra120084020.020 Why?
Kaplan-Meier Estimate1201664690.020 Why?
Ultrasonography, Interventional1201414870.020 Why?
Remission Induction1201123910.020 Why?
Leg1201010870.020 Why?
Leiomyosarcoma120094230.020 Why?
Neoplasm Invasiveness1201335950.020 Why?
Skin Transplantation1201010830.020 Why?
Neoplasm, Residual1200910050.010 Why?
Combined Modality Therapy2201185150.010 Why?
Pelvis120087320.010 Why?
Reproducibility of Results22014200390.010 Why?
Linear Models1201358570.010 Why?
Therapy, Computer-Assisted120052660.010 Why?
Equipment Design1201035010.010 Why?
Survival Analysis12014100750.010 Why?
Carcinoma, Ductal, Breast1200810960.010 Why?
Massachusetts1201388150.010 Why?
Phantoms, Imaging1200825090.010 Why?
Breast1200819610.010 Why?
Neoplasms12008219900.010 Why?
Adolescent42016878320.010 Why?
Chemotherapy, Adjuvant1200635100.010 Why?
Palliative Care1201335680.010 Why?
Lymph Nodes1200834740.010 Why?
Young Adult22016587640.010 Why?
Prevalence12013156410.010 Why?
Antineoplastic Combined Chemotherapy Protocols12016117090.010 Why?
Heart1200843820.010 Why?
Pilot Projects1200685510.010 Why?
Prognosis12013294930.010 Why?
Quality of Life12014132650.010 Why?
Clinical Trials as Topic1200879820.010 Why?
Risk Assessment12013238190.010 Why?
Carcinoma, Non-Small-Cell Lung1200952720.010 Why?
Cohort Studies12013411980.010 Why?
Lung1200899790.010 Why?
Algorithms12007139520.000 Why?
Sex Factors11999104970.000 Why?
Proportional Hazards Models11999124000.000 Why?
United States12013719070.000 Why?
Lung Neoplasms12009132670.000 Why?
Multivariate Analysis11997120470.000 Why?
Child21998797870.000 Why?
O'Farrell's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (135)
Explore
_
Co-Authors (42)
Explore
_
Similar People (59)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.